These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34979242)

  • 21. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study.
    Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan RS; Fermer ML; Gan LM; Lund LH; Lam CSP; Shah SJ
    Circulation; 2020 Nov; 142(21):2029-2044. PubMed ID: 33034202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    Hunter WG; McGarrah RW; Kelly JP; Khouri MG; Craig DM; Haynes C; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Coll Cardiol; 2019 Jan; 73(2):177-186. PubMed ID: 30654890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO
    Klaassen SHC; Liu LCY; Hummel YM; Damman K; van der Meer P; Voors AA; Hoendermis ES; van Veldhuisen DJ
    J Card Fail; 2017 Nov; 23(11):777-782. PubMed ID: 28736291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin 1 Is Associated with Heart Failure Hospitalization and Long-Term Mortality in Patients with Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension.
    Chowdhury MA; Moukarbel GV; Gupta R; Frank SM; Anderson AM; Liu LC; Khouri SJ
    Cardiology; 2019; 143(3-4):124-133. PubMed ID: 31514181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X; Savarese G; Dahlström U; Lund LH; Fu M
    Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
    Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
    Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertension.
    Zafrir B; Carasso S; Goland S; Zilberman L; Klempfner R; Shlomo N; Radzishevsky E; Hasin T; Shotan A; Vazan A; Weinstein JM; Kinany W; Dragu R; Maor E; Grosman-Rimon L; Amir O
    Heart Lung; 2019; 48(6):502-506. PubMed ID: 31174892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis?
    Jiang H; Zhang L; Yu Y; Liu M; Jin X; Zhang P; Yu P; Zhang S; Zhu H; Chen R; Zou Y; Ge J
    J Cell Mol Med; 2014 Nov; 18(11):2189-97. PubMed ID: 25124701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension.
    Son TK; Toan NH; Thang N; Le Trong Tuong H; Tien HA; Thuy NH; Van Minh H; Valensi P
    Cardiovasc Diabetol; 2022 May; 21(1):75. PubMed ID: 35568879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in clinical biochemical indexes of patients with heart failure with preserved ejection fraction or patients with hypertensive heart disease before and after treadmill exercise.
    Yang X; Xing Y; Li K
    Ann Palliat Med; 2021 Jul; 10(7):7970-7976. PubMed ID: 34353083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne's thread.
    De Luca M; Crisci G; Giardino F; Valente V; Amaranto I; Iacono O; D'Assante R; Giallauria F; Marra AM
    Monaldi Arch Chest Dis; 2021 Aug; 92(1):. PubMed ID: 34351104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction.
    Kresoja KP; Rommel KP; Wachter R; Henger S; Besler C; Klöting N; Schnelle M; Hoffmann A; Büttner P; Ceglarek U; Thiele H; Scholz M; Edelmann F; Blüher M; Lurz P
    Eur J Heart Fail; 2021 Oct; 23(10):1633-1644. PubMed ID: 34231954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction.
    Bruno C; Silvestrini A; Calarco R; Favuzzi AMR; Vergani E; Nicolazzi MA; d'Abate C; Meucci E; Mordente A; Landolfi R; Mancini A
    Front Endocrinol (Lausanne); 2020; 11():281. PubMed ID: 32477267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.